ProfileGDS4132 / 237522_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 42% 40% 40% 34% 38% 45% 38% 39% 35% 41% 44% 45% 39% 40% 47% 46% 43% 49% 40% 42% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101109.66742
GSM201543Muscle PCOS pioglitazone 12194.004140
GSM201544Muscle PCOS pioglitazone 161106.08640
GSM201545Muscle PCOS pioglitazone 20192.776634
GSM201829Muscle PCOS pioglitazone 231103.59238
GSM201830Muscle PCOS pioglitazon 251123.3845
GSM201831Muscle PCOS pioglitazone 27196.403238
GSM201832Muscle PCOS pioglitazone 31100.8739
GSM201833Muscle PCOS pioglitazone 4181.954835
GSM201834Muscle PCOS pioglitazone 81105.7841
GSM201835Muscle PCOS after pioglitazone 102101.97544
GSM201836Muscle PCOS after pioglitazone 122108.48445
GSM201837Muscle PCOS after pioglitazone 16284.60639
GSM201838Muscle PCOS after pioglitazone 20294.298440
GSM201839Muscle PCOS after pioglitazone 232118.24547
GSM201840Muscle PCOS after pioglitazone 252115.95346
GSM201841Muscle PCOS after pioglitazone 27296.689743
GSM201842Muscle PCOS after pioglitazone 32108.14549
GSM201843Muscle PCOS after pioglitazone 4298.920740
GSM201844Muscle PCOS after pioglitazone 82104.87642